Thomas Di Raimondo Janux Therapeutics, Inc. (JANX) insider trading activity

JANX Quotes by TradingView

Thomas Di Raimondo is Chief Scientific Officer of Janux Therapeutics, Inc.. Currently has a direct ownership of 124,425 shares of JANX, which is worth approximately $3.64 Million. The most recent transaction as insider was on Jan 02, 2026, when has been sold 2,505 shares (Common Stock) at a price of $13.73 per share, resulting in proceeds of $34,393. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 124K
4.08% 3M change
4.08% 12M change
Total Value Held $3.64 Million

Thomas DiRaimondo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Jan 02 2026
SELL
Open market or private sale
$34,393 $13.73 p/Share
2,505 Reduced 1.97%
124,425 Common Stock
Jan 02 2026
BUY
Grant, award, or other acquisition
-
31,400 Added 16.77%
155,825 Common Stock
Jan 02 2025
BUY
Grant, award, or other acquisition
-
24,000 Added 15.61%
129,719 Common Stock
Sep 27 2024
SELL
Open market or private sale
$233,600 $46.72 p/Share
5,000 Reduced 4.86%
97,938 Common Stock
TD

Thomas Di Raimondo

Chief Scientific Officer
San Diego, CA

Track Institutional and Insider Activities on JANX

Follow Janux Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells JANX shares.

Notify only if

Insider Trading

Get notified when an Janux Therapeutics, Inc. insider buys or sells JANX shares.

Notify only if

News

Receive news related to Janux Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on JANX